Product News: Agilent to Discuss Innovative MS Technologies at AACC

09 Jul 2012

Agilent will be exhibiting at the AACC Clinical Lab Expo in LA later this month. The company has also announced that it is to hold a breakfast meeting to discuss innovative MS technologies for analyzing small molecules in biomatrices for clinical research.

With its comprehensive portfolio of industry-leading LC/MS, GC/MS, ICP/MS, and RapidFire/MS solutions, Agilent Technologies can help you to take advantage of the emerging world of clinical research MS, from sample preparation to your final answer.


Ultra Fast and Ultra Sensitive: Innovative Mass Spectrometry Technologies for Analyzing Small Molecules in Biomatrices for Clinical Research

Learn about new innovations from sample preparation to final answers for the analyses of small molecules such as endogenous steroids and drugs in biomatrices. Presentations will also include Agilent’s unique RapidFire technology capable of ultra-fast SPE/MS/MS analyses in the seconds-per-sample time frame as well as highly specific and sensitive LC/MS/MS determinations of low level compounds using Agilent’s industry leading liquid chromatography and triple quadrupole mass spectrometry systems.

William LaMarr, Ph.D.
Application Manager, RapidFire
Agilent Technologies

Andre Szczesniewski
Clinical Applications Engineer
Agilent Technologies

Tuesday, July 17, 2012

Westin Bonaventure Hotel
404 South Figuerosa Street
Los Angeles, California 90071

Beaudry B

7:00 am – 8:30 am

To attend this meeting, register here. 

You can visit Agilent Technologies at the AACC 2012 Clinical Lab Expo, July 17-19, at the Los Angeles Convention Center in Los Angeles, CA - booth 5436.